Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. - Test2 - elhamkhani - TriplyDB

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

http://www.wikidata.org/entity/Q37108533

about

Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS).Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline.Progress towards the child mortality millennium development goal in urban sub-Saharan Africa: the dynamics of population growth, immunization, and access to clean water Global immunization: status, progress, challenges and future.Migration and child immunization in Nigeria: individual- and community-level contexts Health and economic impact of rotavirus vaccination in GAVI-eligible countries Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010 Trends in immunization completion and disparities in the context of health reforms: the case study of Tanzania Global cost of child survival: estimates from country-level validation.Economic value of dengue vaccine in Thailand.Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district.Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunisation clinic in Ghana Vaccine production, distribution, access, and uptake.Hepatitis B: Epidemiology and prevention in developing countries.Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study.RETRACTED: Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries Are the poor differentially benefiting from provision of priority public health services? A benefit incidence analysis in Nigeria.SMS text message reminders to improve infant vaccination coverage in Guatemala: A pilot randomized controlled trial.Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.The cost effectiveness of rotavirus vaccination in Iran Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.Funding gap for immunization across 94 low- and middle-income countries.The cost-effectiveness of rotavirus vaccination in Malawi.Metal-Organic Framework as a Protective Coating for Biodiagnostic Chips.Silk-Encapsulated Plasmonic Biochips with Enhanced Thermal Stability.The effect of social determinants on immunization programs.The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies.Scaling up family planning in Sierra Leone: A prospective cost-benefit analysis.Advances in T-cell epitope engineering.Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies.Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.

P2860

Q27331006-2F8022B9-B7F7-4FB0-AADC-DA7E0C392D5A Q27980656-C9EA75DA-2632-401B-89B4-0CF0AE915CCF Q28074172-1B089876-B676-41A6-91EE-B0E3C9487ED5 Q28476526-48CB4CF9-F1B4-41E6-9C96-E9ADE7F806B7 Q31038896-E9199AAE-899E-4B36-8945-D910FA225532 Q31152120-8F109FD4-0905-4995-99DF-187F84DDEB8A Q33295354-FC656B0F-B628-49D3-8580-2C81131B9277 Q33510451-C86031C5-94AA-4995-B44B-840E3989D9F2 Q33538357-4A89A481-4FD2-499A-AAA8-A12365A96758 Q33578406-C6A7790E-A3FB-4EBA-A859-1386723EF0AA Q33868334-B320F5C3-BFB9-4387-B519-1228141BAEC6 Q34097272-086F3897-CA24-436A-A1D8-114EF23EF090 Q34321903-6A061AC3-CC7B-451A-B6AB-FBF3E145739F Q34734611-40218148-0ACB-4518-A884-16F4BCBA7454 Q34875673-4F2373C8-E943-43FC-BA66-6113C88BF59B Q35068374-794F49C6-B566-46AA-81B6-FED401B09430 Q35086486-1A35E479-848F-4284-B593-D8209F0AB243 Q35188985-E94106D4-3C83-433D-A2A7-AC9A1C2C8734 Q35875838-C5FE6027-AC5E-4235-9E5B-4BE2AA81C75F Q36087645-5FCEC16C-FA40-4245-B7FF-BE6C44428C36 Q36132649-F11BD4FF-2CDB-4152-A9AA-97562F2748CD Q36358918-74A126C9-9A4D-40B9-ABF1-237047261DBA Q36430614-1B13BC00-0845-4DF8-BD30-BBE2236D95EB Q36879300-3F557EE9-5D85-49FC-8A37-FD1215881650 Q37087055-071ABD7E-24E1-453B-9D04-B08C6FF8F951 Q37135008-8BFFD120-52B8-49CF-AB10-75C1DEF0B078 Q37398811-86585143-FA36-4ADE-8EFB-832EAACA23CF Q37481296-31A0319B-84D4-425F-9956-57E8A6B143F3 Q37655326-2916DE1C-9403-4A63-9E97-2C19D31C6AEF Q37725100-B82288B2-C019-4E67-BF88-6EA215662200 Q37727883-B12C8C0B-4346-456E-81E1-C636A651D257 Q37983415-784F90CD-EBE8-45E9-A15B-F016A916F886 Q38561977-EDB416A5-8DB0-44A6-9172-080F60ACCEBB Q40041613-461B068A-2C20-4596-8DD5-D86CA5EF2036 Q41533770-C80BFB52-CFCC-4294-A971-05740902486C Q42200855-1C0F7A98-B83B-432D-BBE0-8BD1C43C8175 Q42250656-0E746133-0365-45DF-A33E-F2A3BB7B5F03 Q42276398-7AB947AE-AA60-419C-9AEF-62455781FCF2 Q42847874-CBE2F237-4462-4155-92F1-2467E5ED3697 Q43924180-7649C16E-A355-4689-A59E-818461136445

P2860

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

http://www.wikidata.org/entity/Q37108533

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@en

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@nl

type

label

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@en

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@nl

prefLabel

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@en

Estimating the costs of achiev ...... ision and Strategy, 2006-2015.

@nl

P1433

Q37108533-9377426E-3B20-437E-A17C-08DE9EAD7488

P1476

Q37108533-AECB55CC-77BE-4A3F-B86D-CB3C60E84F55

P2093

Q37108533-21EE5E07-693C-4952-93AC-5EC848F7DC28

Q37108533-43DCC85D-7587-4898-A6AC-295613CB0B73

Q37108533-4A4419AA-9ED8-4CAF-99C6-EFD7AD02E24F

Q37108533-61BD8BC9-A70D-422C-862D-7AB5AD5FC89F

Q37108533-6EFA587B-9A04-4337-B666-BF680C50F437

Q37108533-86A26A8A-99A3-4FEC-9B59-08774532F304

Q37108533-974256FE-3F51-467E-95AE-2B9C54E81EC3

Q37108533-9753F2A2-717B-4615-9E2D-DFF243CAA97E

Q37108533-E3E1E4BA-333F-48C3-B512-CC11F06D6A5C

P2860

Q37108533-37EFFAAF-17DF-453F-8278-4980127B6577

Q37108533-710606A2-198B-493E-89E0-C5EDA288E2A5

Q37108533-833DAB81-9D42-42D3-A8D0-4D8E706681B3

Q37108533-860843B6-D049-403E-95E4-8DC5286B4DF7

Q37108533-B618A3C8-1CF6-4A96-82CC-99D7F86EE4A6

Q37108533-C3FF2CE6-4764-4831-93A3-D694C183CC8F

Q37108533-E05971B0-B4E7-4432-9FC9-B93E1D5CBA0E

Q37108533-E41F2EE1-CA64-4AEA-8E71-AE1345CE7B46

Q37108533-EBE5EE67-5010-4A78-B59D-4A3A329F40EE

P304

Q37108533-9D8F9E5C-6CEF-4223-95E8-1941042E1689

P31

Q37108533-5752A41E-7A15-4C83-972B-515BCBE98262

P356

Q37108533-495EAB49-F5E8-467A-BC2C-21BE63AE90F4

P407

Q37108533-2D748810-DC70-44C2-94A3-BA196270DDB5

P433

Q37108533-4250046C-635F-4CE4-AB2F-87ECF8784BB4

P478

Q37108533-35475894-D10D-4D7B-90BA-95AAA5EC7817

P50

Q37108533-79D6469A-EC09-4F8C-8051-F393E0586718

P577

Q37108533-0D8D976E-DA7F-4112-BCBB-CF737D27CBEA

P698

Q37108533-9130D54D-A2C5-411E-AB8D-7123ABE367BB

P921

Q37108533-3EF2CB88-4985-4883-94E7-71E903B061B0

Q37108533-685E05CE-DC19-4C61-B1CC-D3A4402F7910

P932

Q37108533-6BF16D88-D959-4650-8F25-E68C9C5B8C37

P356

P1433

Bulletin of the World Health Organization

P1476

Estimating the costs of achiev ...... Vision and Strategy, 2006-2015

@en

P2093

Abdelmajid Tibouti

http://www.w3.org/2001/XMLSchema#string

Ahmed Magan

http://www.w3.org/2001/XMLSchema#string

Benjamin Johns

http://www.w3.org/2001/XMLSchema#string

François Gasse

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Okwo-Bele

http://www.w3.org/2001/XMLSchema#string

Patrick Lydon

http://www.w3.org/2001/XMLSchema#string

Peter Salama

http://www.w3.org/2001/XMLSchema#string

Raymond Hutubessy

http://www.w3.org/2001/XMLSchema#string

Shook-Pui Lee-Martin

http://www.w3.org/2001/XMLSchema#string

P2860

The real and the nominal? Making inflationary adjustments to cost and other economic data.

Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program.

Financial challenges of immunization: a look at GAVI.

Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.

Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003.

Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

A new global immunisation vision and strategy.

Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.

The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?

P304

27-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2471/BLT.07.045096

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18235887

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

P932

2647343

http://www.w3.org/2001/XMLSchema#string